Nicholas J. Montarello

Apr 27, 2023 | citoday.com | Nicholas J. Montarello |Lars Søndergaard |Ole De Backer

Transcatheter aortic valve replacement (TAVR) has become the therapeutic standard of care for patients with severe symptomatic aortic stenosis (AS) across all surgical risk categories,1-5 and the use of TAVR has been expanding to younger patients following the updated guidelines for the management of valvular heart disease.6-8 The European guidelines recommend that patients aged ≥ 75 years should receive TAVR rather than surgical aortic valve replacement (SAVR), whereas the United States...